Xencor Inc (XNCR):企業の財務・戦略的SWOT分析

◆英語タイトル:Xencor Inc (XNCR) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH138584FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Xencor Inc (Xencor) is a clinical-stage biopharmaceutical company. It develops engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer. The company provides pipeline products under preclinical development such as XmAb14045, for the treatment of acute myeloid leukemia; XmAb5871, for treating IgG4-related disease, and also for the treatment of systemic lupus erythematosus; XmAb7195. It offers treatment services which are being developed for asthma and allergic diseases; and XmAb13676, used in the treatment of B-cell malignancies. Xencor utilizes its proprietary XmAb technology platform to develop next generation antibody product candidates. The company’s works in partnership with pharmaceutical and biotechnology companies such as Morphosys, Janssen, Amgen, Novartis and others for their research and development activities. Xencor is headquartered in Monrovia, California, the US.

Xencor Inc Key Recent Developments

Mar 10,2021: Xencor to present preclinical data from four preclinical XmAb bispecific antibody and cytokine programs at the American Association for Cancer Research (AACR) Annual Meeting 2021
Mar 03,2021: Xencor to Present at the Barclays Global Healthcare Conference
Feb 23,2021: Xencor reports fourth quarter and full year 2020 financial results
Feb 16,2021: Xencor to Host Fourth Quarter and Full Year 2020 Financial Results Webcast and Conference Call on February 23, 2021

This comprehensive SWOT profile of Xencor Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Xencor Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Xencor Inc – Key Information
Xencor Inc – Overview
Xencor Inc – Key Employees
Xencor Inc – Key Employee Biographies
Xencor Inc – Key Operational Heads
Xencor Inc – Major Products and Services
Xencor Inc – History
Xencor Inc – Company Statement
Xencor Inc – Locations And Subsidiaries
Xencor Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Xencor Inc – Business Description
Xencor Inc – Corporate Strategy
Xencor Inc – SWOT Analysis
SWOT Analysis – Overview
Xencor Inc – Strengths
Xencor Inc – Weaknesses
Xencor Inc – Opportunities
Xencor Inc – Threats
Xencor Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Xencor Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Xencor Inc, Key Information
Xencor Inc, Key Ratios
Xencor Inc, Share Data
Xencor Inc, Major Products and Services
Xencor Inc, History
Xencor Inc, Key Employees
Xencor Inc, Key Employee Biographies
Xencor Inc, Key Operational Heads
Xencor Inc, Other Locations
Xencor Inc, Subsidiaries
Xencor Inc, Key Competitors
Xencor Inc, SWOT Analysis
Xencor Inc, Ratios based on current share price
Xencor Inc, Annual Ratios
Xencor Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Xencor Inc (XNCR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Axpo Holding AG-エネルギー分野:企業M&A・提携分析
    Summary Axpo Holding AG (Axpo) is an electricity utility that produces, trades and sells electricity. It is wholly owned by the cantons of Northeastern Switzerland. The company covers the entire value chain from power generation and marketing of a wide range of products to power distribution. It gen …
  • Benesse Holdings, Inc. (9783):企業の財務・戦略的SWOT分析
    Benesse Holdings, Inc. (9783) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Cummins Inc (CMI)-エネルギー分野:企業M&A・提携分析
    Summary Cummins Inc. (Cummins) is a manufacturer of diesel engines and related technologies. It designs, manufactures, services and distributes engines and related component solutions. The company offers filtration, fuel systems, control systems, after treatment devices, turbochargers, air handling …
  • Inova Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Inova Diagnostics Inc (Inova), a subsidiary of Werfen Life Group SAU is a medical device company that develops and commercializes new autoimmune technologies and diagnostic markers. The company's diagnostic reagent products include quanta flash used for semi-quantitative determination of aut …
  • Graham Holdings Company (GHC):企業の財務・戦略的SWOT分析
    Graham Holdings Company (GHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Debiotech SA-医療機器分野:企業M&A・提携分析
    Summary Debiotech SA (Debiotech) is a medical device company that develops therapeutic devices and diagnostic products. The company’s products include patch-pump, injection, multi-fluidic cassette type system, infusion pump and microsystems. It develops products in the areas of implantable and exter …
  • Cantel Medical Corp. (CMD)-医療機器分野:企業M&A・提携分析
    Summary Cantel Medical Corp. (Cantel) is a manufacturer and distributor of infection prevention and control products and services to the healthcare market. The company’s product portfolio includes water purification equipment, sterilants, disinfectants and cleaners, specialized medical device reproc …
  • Poxel SA (POXEL):企業の財務・戦略的SWOT分析
    Summary Poxel SA (Poxel) is a biopharmaceutical company that focuses to develop drugs for metabolic diseases. The company’s pipeline product portfolio includes Imeglimin, which is developed to target mitochondrial dysfunction, for the treatment of type 2 diabetes; PXL065, a mitochondrial pyruvate ca …
  • Daepyung Co., Ltd.:戦略・SWOT・企業財務分析
    Daepyung Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daepyung Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Moody’s Corporation:企業のM&A・事業提携・投資動向
    Moody's Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Moody's Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Berkshire Hathaway Inc:企業の戦略・SWOT・財務情報
    Berkshire Hathaway Inc - Strategy, SWOT and Corporate Finance Report Summary Berkshire Hathaway Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • George Weston Ltd (WN):企業の財務・戦略的SWOT分析
    George Weston Ltd (WN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Caladrius Biosciences Inc (CLBS):企業の財務・戦略的SWOT分析
    Summary Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc, is a clinical-stage biopharmaceutical company. The company develops cellular therapies for the treatment cardiovascular indications and autoimmune diseases. The company's products pipeline includes CLBS03 is an autologous ex vivo p …
  • Diffusion Pharmaceuticals Inc (DFFN):企業の財務・戦略的SWOT分析
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a clinical stage biotechnology company that develops standard of care therapies. The company improves cancer treatments such as radiation therapy and chemotherapy in treatment-resistant solid tumors, includi …
  • Dermira Inc (DERM):製薬・医療:M&Aディール及び事業提携情報
    Summary Dermira Inc (Dermira) is a biopharmaceutical company that identifies, develops and commercializes therapeutic solutions for the treatment of dermatologic diseases, such as hyperhidrosis, acne vulgaris and atopic dermatitis. The company’s product includes QBREXZA (glycopyrronium) cloth, an an …
  • DBS Bank (Hong Kong) Limited:企業の戦略・SWOT・財務情報
    DBS Bank (Hong Kong) Limited - Strategy, SWOT and Corporate Finance Report Summary DBS Bank (Hong Kong) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Qc Holdings Inc
    Qc Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Qc Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Smith & Nephew Plc (SN.)-製薬・医療分野:企業M&A・提携分析
    Summary Smith & Nephew Plc (Smith & Nephew) develops, manufactures and markets medical devices for use in orthopedic reconstruction, orthopedic trauma and clinical therapies, sports medicines and advanced wound management. The company offers its products in various categories including Sports Medici …
  • Rex Energy Corporation (REXX)-石油・ガス分野:企業M&A・提携分析
    Summary Rex Energy Corporation (Rex Energy) is an independent energy company. It carries out the acquisition, production, exploration and development of condensate, natural gas and natural gas liquids. It holds properties in Appalachian Basin. Rex Energy focuses on drilling and exploration activitie …
  • Hague and London Oil PLC (HNL):企業の財務・戦略的SWOT分析
    Summary Hague and London Oil PLC (HALO), formerly Wessex Exploration plc, is an oil and gas exploration company that develops resource properties. The company acquires, explores, produces, and develops oil and gas resource properties across the UK. Its projects comprise assets in the Philippines, Gu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆